Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
EBITDA history
Currency unavailable · from the income statement
No EBITDA data reported for this period type.
EBITDA vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -$53.92M USD | -39.7% | — | — | |
| LTM Mar 2026 | -$75.47M USD | +22.0% | — | 33540.9% | |
| FY2025 | -$76.5M USD | — | — | 410.9% | |
| LTM Jun 2026 | -$254.91M USD | -32.5% | — | 3579.7% | |
| LTM Jun 2026 | -$821.8M USD | -62.8% | — | 1158.1% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -36.1% | — | 2368.9% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.